49 related articles for article (PubMed ID: 36434945)
1. Pharmacogenetics as a predictor chemotherapy induced peripheral neuropathy in gynecologic cancer patients treated with Taxane-based chemotherapy.
Mysona D; Dorr K; Ward A; Shaver E; Rungruang B; Ghamande S
Gynecol Oncol; 2023 Jan; 168():114-118. PubMed ID: 36434945
[TBL] [Abstract][Full Text] [Related]
2. Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk.
Bao T; Basal C; Seluzicki C; Li SQ; Seidman AD; Mao JJ
Breast Cancer Res Treat; 2016 Sep; 159(2):327-33. PubMed ID: 27510185
[TBL] [Abstract][Full Text] [Related]
3. Electroacupuncture use for treatment of taxane-induced peripheral neuropathy in patients with breast cancer: protocol for a pilot, randomised, blinded, sham-controlled trial (EA for CIPN).
Choi V; Park SB; Lacey J; Kumar S; Heller G; Grimison P
BMJ Open; 2024 Jan; 14(1):e076391. PubMed ID: 38195173
[TBL] [Abstract][Full Text] [Related]
4. Candidate pathway-based genetic association study of platinum and platinum-taxane related toxicity in a cohort of primary lung cancer patients.
Johnson C; Pankratz VS; Velazquez AI; Aakre JA; Loprinzi CL; Staff NP; Windebank AJ; Yang P
J Neurol Sci; 2015 Feb; 349(1-2):124-8. PubMed ID: 25586538
[TBL] [Abstract][Full Text] [Related]
5. Similarities in the Neuropathy Phenotype of Cancer Survivors Who Received Different Classes of Chemotherapy Drugs.
Miaskowski C; Levine JD; Paul SM; Cooper B; Abrams G; Topp K; Cheung S; Henderson-Sabes J; Conley YP; Snowberg K; Alfaro E; Quinn M; Kober KM
J Pain; 2022 Sep; 23(9):1604-1615. PubMed ID: 35533976
[TBL] [Abstract][Full Text] [Related]
6. Association between Genetic Variants and Peripheral Neuropathy in Patients with NSCLC Treated with First-Line Platinum-Based Therapy.
de Jong C; Herder GJM; van Haarlem SWA; van der Meer FS; van Lindert ASR; Ten Heuvel A; Brouwer J; Egberts TCG; Deneer VHM
Genes (Basel); 2023 Jan; 14(1):. PubMed ID: 36672910
[TBL] [Abstract][Full Text] [Related]
7. Metabolic and lifestyle risk factors for chemotherapy-induced peripheral neuropathy in taxane and platinum-treated patients: a systematic review.
Timmins HC; Mizrahi D; Li T; Kiernan MC; Goldstein D; Park SB
J Cancer Surviv; 2023 Feb; 17(1):222-236. PubMed ID: 33438175
[TBL] [Abstract][Full Text] [Related]
8. Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.
Monfort SM; Pan X; Patrick R; Ramaswamy B; Wesolowski R; Naughton MJ; Loprinzi CL; Chaudhari AMW; Lustberg MB
Breast Cancer Res Treat; 2017 Jul; 164(1):69-77. PubMed ID: 28374323
[TBL] [Abstract][Full Text] [Related]
9. Plasma Lipidomic Profiling Identifies Elevated Triglycerides as Potential Risk Factor in Chemotherapy-Induced Peripheral Neuropathy.
Yeung N; Li T; Lin HM; Timmins HC; Goldstein D; Harrison M; Friedlander M; Mahon KL; Giles C; Meikle PJ; Park SB; Horvath LG
JCO Precis Oncol; 2024 Apr; 8():e2300690. PubMed ID: 38691814
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D Insufficiency as a Risk Factor for Paclitaxel-Induced Peripheral Neuropathy in SWOG S0221.
Chen CS; Zirpoli G; Barlow WE; Budd GT; McKiver B; Pusztai L; Hortobagyi GN; Albain KS; Damaj MI; Godwin AK; Thompson A; Henry NL; Ambrosone CB; Stringer KA; Hertz DL
J Natl Compr Canc Netw; 2023 Nov; 21(11):1172-1180.e3. PubMed ID: 37935109
[TBL] [Abstract][Full Text] [Related]
11. Randomized adaptive selection trial of cryotherapy, compression therapy, and placebo to prevent taxane-induced peripheral neuropathy in patients with breast cancer.
Accordino MK; Lee S; Leu CS; Levin B; Trivedi MS; Crew KD; Kalinsky K; Raghunathan R; Faheem K; Harden E; Taboada A; de Oliveira BD; Larson E; Franks L; Honan E; Law C; Hershman DL
Breast Cancer Res Treat; 2024 Feb; 204(1):49-59. PubMed ID: 38060077
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic effects of compression therapy on taxane-induced peripheral neuropathy incidence, negative emotions, and sleep disorders in patients with breast cancer.
Dongxue G; Ran L; Fangfei Z; Zirui Z; Lizhi Z
Support Care Cancer; 2024 Apr; 32(4):260. PubMed ID: 38561474
[TBL] [Abstract][Full Text] [Related]
13. Exploring assessment of balance using virtual reality in patients at risk of chemotherapy-induced peripheral neuropathy.
Teng C; Chiarovano E; Tighe D; Bui KT; Venkatesha ; Blinman PL; MacDougall HG; Vardy JL
Intern Med J; 2023 Aug; 53(8):1356-1365. PubMed ID: 35762188
[TBL] [Abstract][Full Text] [Related]
14. Effect of gradient pressure therapy on the prevention of chemotherapy-induced peripheral neuropathy in patients with breast cancer.
Dongxue G; Fangfei Z; Ran L; Lizhi Z
Support Care Cancer; 2024 May; 32(6):367. PubMed ID: 38761270
[TBL] [Abstract][Full Text] [Related]
15. Effects of taxane-induced peripheral neuropathy on hand dexterity impairment: evaluation of quantitative and subjective assessments.
Manfuku M; Inoue J; Yamanaka N; Kanamori H; Sumiyoshi K; Osumi M
Support Care Cancer; 2024 Apr; 32(5):304. PubMed ID: 38652168
[TBL] [Abstract][Full Text] [Related]
16. Abnormal photoplethysmography waveforms are associated with chemotherapy induced neuropathy.
Bryce Y; Santos-Martin E; Ziv E; Gonzalez-Aguirre A; Moussa A; Friedman A; Maybody M
Vasa; 2022 Mar; 51(2):85-92. PubMed ID: 35130713
[No Abstract] [Full Text] [Related]
17. Risk factors of paclitaxel-induced peripheral neuropathy in patients with breast cancer: a prospective cohort study.
Lixian S; Xiaoqian Y; Luyan G; Lizhi Z; Rui D; Hongyue Y; Caijie Z; Fenghui Y
Front Oncol; 2024; 14():1327318. PubMed ID: 38515579
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 Oxidoreductase (POR) Associated with Severe Paclitaxel-Induced Peripheral Neuropathy in Patients of European Ancestry from ECOG-ACRIN E5103.
Shen F; Jiang G; Philips S; Gardner L; Xue G; Cantor E; Ly RC; Osei W; Wu X; Dang C; Northfelt D; Skaar T; Miller KD; Sledge GW; Schneider BP
Clin Cancer Res; 2023 Jul; 29(13):2494-2500. PubMed ID: 37126018
[TBL] [Abstract][Full Text] [Related]
19. Impact of exercise on chemotherapy-induced peripheral neuropathy in survivors with post-treatment primary breast cancer.
Saint K; Nemirovsky D; Lessing A; Chen Y; Yang M; Underwood WP; Galantino ML; Jones LW; Bao T
Breast Cancer Res Treat; 2024 May; ():. PubMed ID: 38713289
[TBL] [Abstract][Full Text] [Related]
20. NeuroPredict: study of the predictive value of ABCB1 genetic polymorphisms and associated clinical factors in chronic chemotherapy-induced peripheral neuropathy (CIPN).
Vargas-Aliaga A; De la Haba M; Contreras MJ; Morales Estevez C; Porras I; Cano MT; Pulido G; Gómez MA; Flores-Paco P; Juan HR; Aranda E
Front Pharmacol; 2024; 15():1352939. PubMed ID: 38469410
[No Abstract] [Full Text] [Related]
[Next] [New Search]